AlexHerreraMD

PubMed

• 2 citations
  CD19-directed CART therapy for T-cell/histiocyte-rich large B-cell lymphoma.
  Priyanka A Pophali, Joshua A Fein, Kwang W Ahn, Molly Allbee-Johnson, Nausheen Ahmed
  Blood Advances. 2024-10-22
• Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma.
  Swetha Kambhampati Thiruvengadam, Matthew G Mei, Lu Chen, Sandrine Puverel, Robert Chen
  Clinical Lymphoma, Myeloma & Leukemia. 2024-10-01
• Yttrium-90 anti-CD25 BEAM conditioning for autologous hematopoietic cell transplantation in Peripheral T-cell lymphoma.
  Jasmine Zain, Ni-Chun Tsai, Joycelynne Palmer, Jennifer Simpson, Vikram Adhikarla
  Blood Advances. 2024-09-24

Journal Articles

• Burkitt leukemia limited to the bone marrow has a better prognosis than Burkitt lymphoma with bone marrow involvement in adults  
  Song JY, Venkataraman G, Fedoriw Y, Siddiqi T, Alikhan MB, Kim YS, Murata-Collins J, Weisenburger DD, Liu X, Duffield AS, Leuk Lymphoma, 1/1/2015
• Ibrutinib in the Treatment of Mantle Cell Lymphoma  
  Herrera AF, Jacobsen EJ, Clin Cancer Res, 1/1/2014

Books/Book Chapters

• Reference Module in Biomedical Sciences 
  Chapter: Lymphoma, Non-Hodgkin’s 
  Herrera AF, Longo DLEditors: Caplan M.Elsevier2014

Abstracts/Posters

• CD19-Targeting CAR-T Cell Therapy in CNS Lymphoma
  Alex F. Herrera, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Outcome of Autologous Stem Cell Transplantation Following PD-(L)1 Based Salvage Therapy for Multiply Relapsed Patients with Classic Hodgkin Lymphoma
  Alex F. Herrera, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Preliminary Results from a Phase I Trial of Pembrolizumab Plus Vorinostat in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, a...
  Alex F. Herrera, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Initial Findings of the Phase 1 Trial of PBCAR0191, a CD19 Targeted Allogeneic CAR-T Cell Therapy
  Alex F. Herrera, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Genomic Characterization of Diffuse Large B-Cell Lymphoma Transformation from Nodular Lymphocyte Predominant Hodgkin Lymphoma
  Alex F. Herrera, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Long Term Outcomes of Patients with Aggressive T-Cell Non-Hodgkin Lymphoma Undergoing Allogeneic Stem Cell Transplantation: Retrospective Results from a Single Center
  Alex F. Herrera, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Polatuzumab Vedotin Plus Bendamustine with Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Updated Results of a Phase Ib/II Randomized Study
  Alex F. Herrera, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplant after Programmed Cell Death 1 (PD-1) / Programmed Cell Death Ligand 1 (PD-L1) Blockade for Classic...
  Alex F. Herrera, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Post-Marketing Use Outcomes of an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, Axicabtagene Ciloleucel (Axi-Cel), for the Treatment of Large B Cell Lympho...
  Alex F. Herrera, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Three-Year Follow-up of Keynote-087: Pembrolizumab Monotherapy in Relapsed/Refractory Classic Hodgkin Lymphoma
  Alex F. Herrera, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Brentuximab Vedotin and Nivolumab for Relapsed or Refractory Classic Hodgkin Lymphoma: Long-Term Follow-up Results from the Single-Arm Phase 1/2 Study
  Alex F. Herrera, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Sequencing-Based Detection of Circulating Tumor DNA in the Autologous Stem Cell Grafts of Patients with Diffuse Large B-cell Lymphoma Undergoing Hematopoietic Stem Cel...
  Merryman RW, Katherine A. Kong3, Heather Sun4, Jennifer R. Brown5, Matthew S. Davids5, David C. Fisher5, Eric D. Jacobsen5, Caron A. Jacobson5, Haesook T. Kim6, Ann S...., 57th American Society of Hematology Annual Meeting and Exposition, Orlando, FL, 1/1/2015
• Double Expressing (MYC/BCL2) and Double-Hit Diffuse Large B-cell Lymphomas Have Inferior Survival Following Autologous Stem Cell Transplantation
  Mei M, Lawrence Low2, Reid W. Merryman3, Joo Y. Song2, Victoria Bedell2, Heather Sun4, Tanya Paris5, Tracey Stiller5, Jennifer R. Brown6, Elizabeth Budde1, Robert Chen..., 57th American Society of Hematology Annual Meeting and Exposition, Orlando, FL, 1/1/2015
• Sequencing-Based Detection of Minimal Residual Disease Is Associated with Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Lymphoid M...
  Kim HT, Sun H, Sohani A, Alyea EP, Cutler CS, Ho VT, Koreth J, Nikiforow S, Ritz J, Rodig SJ, Soiffer RJ, Antin JH, Armand P, 56th American Society of Hematology Annual Meeting and Exposition, San Francisco, CA, 1/1/2014
• A Phase II Study Of Proteasome-Inhibition For Initial Therapy Of Chronic Graft-Versus-Host Disease
  Kim HT, Bindra B, Alyea EP, Armand P, Cutler CS, Ho VT, Ritz J, Blazar BR, Antin JH, Soiffer RJ, Koreth J, 55th American Society of Hematology Annual Meeting and Exposition, New Orleans, LA, 1/1/2013
• Histopathology of “Cord Colitis Syndrome” in Umbilical Cord Blood Transplant Recipients
  Bellizzi AM, Soriano G, Marty FM, Hornick JL, 101st Annual Meeting of the United States and Canadian Academy of Pathology, Vancouver, British Columbia, Canada, 1/1/2012
• Next-Generation Sequencing for the Identification of Transplantation-Associated Pathogens
  Bhatt AS, Freeman SS, Pedamallu CS, Gevers D, Duke F, Jung J, Michaud M, Walker BJ, Young S, Earl AM, Kostic AD, Ojesina AI, Hobbs G, Antin JH, Soiffer RJ, Baden LR, G..., 54th American Society of Hematology Annual Meeting and Exposition, Atlanta, GA, 1/1/2012
• Comparison of Referring and Final Pathology for T-Cell Lymphomas in the NCCN
  Crosby-Thompson A, Friedberg JW, Abel GA, Czuczman MS, Gordon LI, Kaminski MS, Millenson M, Nademanee A, Niland J, Rodriguez MA, Zelenetz AD, LaCasce AS, 54th American Society of Hematology Annual Meeting and Exposition, Atlanta, GA, 1/1/2012
• Cord Colitis: An Antibiotic-Responsive Colitis Syndrome Following Cord Blood Stem Cell Transplantation
  Soriano G, Hornick JL, Gilmore E, Ho VT, Ballen KK, Baden LR, Cutler CS, Antin JH, Soiffer RJ, Marty FM, 52nd American Society of Hematology Annual Meeting and Exposition, Orlando, FL, 1/1/2010
• A Pilot Study to Develop Clinical Case Definitions for the Rapid Diagnosis of MDR-TB in Resource Limited Settings
  Ngubane L, Hurtado R, Alvarez GG, Meintjes G, Maartens G, Dong K, Wilson D, DDCF Clinical Research Fellowship Meeting; South African TB Conference, Philadelphia, 2008; Durban, South Africa, 2008, 1/1/2008
• WHO TB retreatment category predicts resistance in hospitalized TB retreatment patients in a high HIV prevalence region
  Schreiber YS, Wilson D, Wallengren K, Draper R, Muller J, Dawood H, Doucette S, Cameron DW, Alvarez GG, 39th Union World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease, Paris, France, 1/1/2008
• A Pilot Study to Develop Clinical Case Definitions for the Rapid Diagnosis of MDR-TB in Resource Limited Settings
  Ngubane L, Hurtado R, Alvarez GG, Meintjes G, Maartens G, Dong K, Wilson D, 39th Union World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease, Paris, France, 1/1/2008
• Radiographic changes in Ductal Carcinoma in Situ Associated with Short-Term Hormonal Therapy
  Hwang ES, Wolverton D, Esserman LJ, Chen YY, Ewing C, Lessing J, Gibbs J, Johnson L, Nyante S, Shim V, Hylton N, 28th San Antonio Breast Cancer Symposium, 1/1/2005
• Magnetic Resonance Imaging Reflects the Biology of Ductal Carcinoma In Situ
  Esserman LJ, Kumar AS, Leung J, Au A, Chen YY, Moore DH, Chen DF, Hellawell J, Wolverton D, Hwang ES, Hylton NM, 27th San Antonio Breast Cancer Symposium, 1/1/2004
• Join now to see all

Lectures

• Future of Maintenance Therapy After Transplant in Relapsed Hodgkin Lymphoma: How Do We Do It Best? 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
• Preliminary Results from a Phase 2 Trial of Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (CHEP-BV) Followed By BV Consolidation in... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Hodgkin Lymphoma: Beyond ABVD for Everyone 
  60th American Society of Hematology Annual Meeting - 12/1/2018
• Phase 1/2 Study of Brentuximab Vedotin in Combination with Nivolumab in Patients with Relapsed or Refractory Classic Hodgkin Lymphoma: Part 3 (Concurrent Dosing) Resul... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B-Cell Lymphoma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Checkpoint Blockade Therapy May Sensitize Aggressive and Indolent Non-Hodgkin Lymphoma to Subsequent Therapy 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Checkpoint Blockade Therapy May Sensitize Hodgkin Lymphoma to Subsequent Therapy 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Phase 1 Study of MDR1 Inhibitor Plus Brentuximab Vedotin in Relapsed/Refractory Hodgkin Lymphoma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• PD-1 Blockade with Pembrolizumab for Classical Hodgkin Lymphoma after Autologous Stem Cell Transplantation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Polatuzumab Vedotin (Pola) Plus Bendamustine (B) with Rituximab (R) or Obinutuzumab (G) in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Updated Res... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Testicular Lymphoma 
  1/1/2014
• 25 year-old male with nasal congestion – a case of EBV-associated extranodal NK/T-cell lymphoma, nasal type 
  1/1/2013
• Cord Colitis Syndrome in Cord-Blood Stem Cell Transplantation 
  1/1/2012
• Join now to see all